Annual Total Liabilities
$2.47 M
-$5.22 M-67.90%
December 1, 2024
Summary
- As of March 10, 2025, VRPX annual total liabilities is $2.47 million, with the most recent change of -$5.22 million (-67.90%) on December 1, 2024.
- During the last 3 years, VRPX annual total liabilities has risen by +$381.70 thousand (+18.28%).
- VRPX annual total liabilities is now -67.90% below its all-time high of $7.69 million, reached on December 31, 2023.
Performance
VRPX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.47 M
+$113.60 K+4.82%
December 1, 2024
Summary
- As of March 10, 2025, VRPX quarterly total liabilities is $2.47 million, with the most recent change of +$113.60 thousand (+4.82%) on December 1, 2024.
- Over the past year, VRPX quarterly total liabilities has stayed the same.
- VRPX quarterly total liabilities is now -67.90% below its all-time high of $7.69 million, reached on December 31, 2023.
Performance
VRPX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
VRPX Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.9% | 0.0% |
| 3 y3 years | +18.3% | +18.3% |
| 5 y5 years | -11.1% | +36.3% |
VRPX Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -67.9% | +18.3% | -67.9% | +18.3% |
| 5 y | 5-year | -67.9% | +18.3% | -67.9% | +36.3% |
| alltime | all time | -67.9% | +96.9% | -67.9% | +36.3% |
Virpax Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $2.47 M(-67.9%) | $2.47 M(+4.8%) |
| Sep 2024 | - | $2.36 M(-56.3%) |
| Jun 2024 | - | $5.39 M(+24.0%) |
| Mar 2024 | - | $4.34 M(-43.5%) |
| Dec 2023 | $7.69 M(+148.6%) | $7.69 M(+17.8%) |
| Sep 2023 | - | $6.53 M(+79.1%) |
| Jun 2023 | - | $3.65 M(+10.7%) |
| Mar 2023 | - | $3.29 M(+6.4%) |
| Dec 2022 | $3.09 M | $3.09 M(-26.5%) |
| Sep 2022 | - | $4.21 M(+69.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $2.48 M(+13.6%) |
| Mar 2022 | - | $2.19 M(+4.8%) |
| Dec 2021 | $2.09 M(-55.4%) | $2.09 M(+15.2%) |
| Sep 2021 | - | $1.81 M(-53.0%) |
| Jun 2021 | - | $3.85 M(+5.2%) |
| Mar 2021 | - | $3.66 M(-21.8%) |
| Dec 2020 | $4.68 M(+68.5%) | $4.68 M(+8.9%) |
| Sep 2020 | - | $4.30 M(+54.6%) |
| Dec 2019 | $2.78 M(+121.6%) | $2.78 M |
| Dec 2018 | $1.25 M | - |
FAQ
- What is Virpax Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals annual total liabilities year-on-year change?
- What is Virpax Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for Virpax Pharmaceuticals?
- What is Virpax Pharmaceuticals quarterly total liabilities year-on-year change?
What is Virpax Pharmaceuticals annual total liabilities?
The current annual total liabilities of VRPX is $2.47 M
What is the all time high annual total liabilities for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high annual total liabilities is $7.69 M
What is Virpax Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, VRPX annual total liabilities has changed by -$5.22 M (-67.90%)
What is Virpax Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of VRPX is $2.47 M
What is the all time high quarterly total liabilities for Virpax Pharmaceuticals?
Virpax Pharmaceuticals all-time high quarterly total liabilities is $7.69 M
What is Virpax Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, VRPX quarterly total liabilities has changed by $0.00 (0.00%)